Navigation Links
OncoSec Medical Closes Purchase and License Agreement for Tumor Therapy Technology with Inovio Pharmaceuticals
Date:4/4/2011

SAN DIEGO, April 4, 2011 /PRNewswire/ -- OncoSec Medical Incorporated (OTCBB: ONCS), a developer of innovative medical approaches to treat solid tumor cancers with unmet medical needs, announced today that on March 24, 2011 it completed its acquisition of certain assets of Inovio Pharmaceuticals, Inc. (NYSE Amex: INO) and entered into a license agreement with Inovio, pursuant to the terms of an asset purchase agreement with Inovio entered into on March 14, 2011.

(Logo:  http://photos.prnewswire.com/prnh/20110314/MM64943LOGO)

OncoSec made an initial payment of $250,000 to Inovio, completing the closing requirements of the purchase and license agreement between the companies. The agreement requires OncoSec to make additional payments of $2.75 million by March 24, 2013, and pay a royalty on commercial product sales. OncoSec has purchased from Inovio certain non-DNA vaccine electroporation technology and intellectual property useful for an electrochemical therapy against solid tumors.  OncoSec has also licensed the right to use this electroporation technology to deliver gene-based cytokineimmune therapies for treating solid tumors.

Punit Dhillon, OncoSec's president and CEO, said: "We are pleased to secure OncoSec's initial funding announced last week and close the asset purchase and license agreement with Inovio. This transaction marks the official launch of OncoSec's plan to develop and commercialize this promising technology for the selective treatment of cancerous tumors. With millions of people in the US alone facing detrimental cosmetic, functional and pain outcomes resulting from the invasive treatments used today for various skin and other cancers, there is a clear need for new therapies to address these unmet needs. These electrochemical and gene-based cytokine therapies have pr
'/>"/>

SOURCE OncoSec Medical Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. OncoSec Medical Licenses Non-DNA Vaccine Tumor Therapy Technology from Inovio Pharmaceuticals
2. Inovio Pharmaceuticals Licenses Non-DNA Vaccine Tumor Therapy Technology to OncoSec Medical
3. OncoSec Medical to Present at ROTH 23rd Annual Growth Stock Conference
4. OncoSec Medical Closes $1.1M Financing
5. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
6. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
7. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
8. Globus Medical Raises $110 Million in Series E Financing Round
9. Quark Pharmaceuticals Appoints New Chief Medical Officer
10. Boston University Biomedical Engineers Find Chink in Bacterias Armor
11. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... -- Sequenom, Inc. (NASDAQ: SQNM ), a life sciences ... of innovative products and services, today announced that its ... operations in Grand Rapids, Michigan ... , North Carolina.  Sequenom Laboratories, cystic fibrosis carrier screen ... North Carolina laboratory location.  "The ...
(Date:5/27/2015)... 27, 2015 PharmaPoint: Type 1 Diabetes - Global ... Type 1 diabetes (T1D) is an autoimmune disease that permanently ... the body can no longer produce insulin. Over the last ... present, no other treatment can be offered to a patient ... analogs with different times of action - long-acting as well ...
(Date:5/27/2015)... NEW YORK , May 27, 2015 ... impacted by accelerated aging of population and ... and other lifestyles has been growing year after year, ... (PCI) market. PCI cases in China ... year earlier; meanwhile the interventional cardiovascular device industry there ...
Breaking Medicine Technology:Sequenom Laboratories To Consolidate Michigan And North Carolina Facilities 2Sequenom Laboratories To Consolidate Michigan And North Carolina Facilities 3PharmaPoint: Type 1 Diabetes - Global Drug Forecast and Market Analysis to 2023 2PharmaPoint: Type 1 Diabetes - Global Drug Forecast and Market Analysis to 2023 3PharmaPoint: Type 1 Diabetes - Global Drug Forecast and Market Analysis to 2023 4China Interventional Cardiovascular Device Industry Report, 2014-2017 2China Interventional Cardiovascular Device Industry Report, 2014-2017 3
... Corporation (Nasdaq: THOR ), a world leader in ... failing hearts, said today it will be participating in the ... Wednesday, May 11. David V. Smith, executive vice ... the company, beginning at 8:40 a.m., Pacific Daylight Time (11:40 ...
... CINCINNATI, May 6, 2011 Kendle (Nasdaq: ... today announced the Company is postponing its Annual Meeting ... Research, LLC.  The annual meeting had been scheduled for ... 4, 2011, that it has signed a merger agreement ...
Cached Medicine Technology:Kendle Announces Postponement of 2011 Annual Meeting 2Kendle Announces Postponement of 2011 Annual Meeting 3Kendle Announces Postponement of 2011 Annual Meeting 4
(Date:5/27/2015)... May 27, 2015 While hair transplantation ... loss, a new pilot study conducted by a physician ... (ISHRS) has found hair follicle grafting can help treat ... was partially funded by ISHRS, which offers research grants ... hair restoration. , In the past decade, numerous ...
(Date:5/27/2015)... 27, 2015 The new http://www.carsonenergy.com ... Why investors should consider oil and gas investing, the ... wells are drilled, industry news, IRA investing, definitions and ... years of knowledge and experience is now in one ... to be able to access 24 hours a day, ...
(Date:5/27/2015)... 2015 CURE® Magazine and ... mission is to advance research, provide information and support, ... to battle the fifth most common type of cancer, ... start to grow out of control. , “CURE ... every stage of the cancer experience through digital and ...
(Date:5/27/2015)... 27, 2015 Difass USA, a modern ... U.S. with its first three flagship products, Dormiva™, Relaxiva™ ... nationwide through http://www.difassusa.com . , A restful ... productivity, but some people struggle with getting the full ... a sleep aid designed to help you fall asleep ...
(Date:5/27/2015)... Cincinnati, Ohio (PRWEB) May 27, 2015 Cincinnati ... Education & Research for Veterans (CERV) Foundation is proud to ... information fair for women Veterans June 11 at the Freedom ... Reporter Karin Johnson will be the emcee. , This ... and devotion to the nation. The banquet is free ...
Breaking Medicine News(10 mins):Health News:New Research Finds Hair Grafting a Promising Therapy for Chronic Leg Ulcers - International Society of Hair Restoration Surgery Awards Research Grant 2Health News:New Research Finds Hair Grafting a Promising Therapy for Chronic Leg Ulcers - International Society of Hair Restoration Surgery Awards Research Grant 3Health News:Carson Energy Launches Next Generation Investor Website 2Health News:CURE® Magazine and Bladder Cancer Advocacy Network Align to Increase Awareness of Fifth Most Common Type of Cancer 2Health News:CURE® Magazine and Bladder Cancer Advocacy Network Align to Increase Awareness of Fifth Most Common Type of Cancer 3Health News:Supplement Brand Difass USA Launches in the U.S. with Three Flagship Products Designed to Bring Balance Back to Your Life 2Health News:Cincinnati VA Women’s Health Clinic Celebrates Women Veterans at Awards Banquet 2
... could prevent damage during play, study finds , FRIDAY, ... shoulder strength before the season starts may predict the ... report says. , Such knowledge could help the ... study,s author said. , A five-year study of 144 ...
... asthma, study finds, , THURSDAY, July 9 (HealthDay ... likelihood of developing such allergic disorders as eczema ... findings of 24 studies, researchers from the University ... gene -- which is thought to help maintain ...
... , ... and dc axial fans and blowers are now available in Canada from Electro Sonic. ... Chatsworth, CA (PRWEB) July 10, ... electronic component distributor, announced that they have reached a distribution agreement. Under the ...
... have long plagued the military in part because of ... fracture with microcapsules that deliver a drug to bolster ... , That technology might be around the corner, ... University Department of Orthopaedics and director of the ...
... Medical Equipment, a medical and sports injury supplies company, ... Industry." In a bold move to bring change to ... Precision Durable Medical Equipment, through their website http://www.injurysupplies.com ... acquire the equipment they need through their private insurance, ...
... NEWPORT BEACH, Calif., July 10 Many people struggle with ... can come from bad experiences in the past that they ... they are afraid of losing. The yearning comes from pleasurable ... Unfortunately, what is missing as people bounce back and ...
Cached Medicine News:Health News:Scientists Zero In on Elusive 'Allergy Gene' 2Health News:NMB Expands in Canada 2Health News:Team Develops Anti-Infection Technology 2Health News:Local Company Gives Out Injury Supplies at No Cost to Customers 2Health News:Escape From Fears and Yearnings by Living in the Now 2
... door 4 shelves. Over-sized compressor. ... Fluorescent interior lighting. Self-Contained System No plumbing ... Full One Year Warranty on Parts & ... Compressor. Also available as a chromatography ...
... Independent controls for Digital ... series stainless steel front. Anodized aluminum ends. ... series stainless steel floor. , Oversized ... to -30C , Positive seal self-closing ...
... The HC Series Large Capacity Refigerators ... embryos, semen, or biological samples at liquid-nitrogen ... holding times and capacities are available to ... Two low profile HCL models are also ...
Inquire...
Medicine Products: